Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease

Background/Aims: The behavioral and psychological symptoms of dementia (BPSD) detract from the quality of life of not only dementia patients but also their family members and caregivers. Donepezil is used to treat Alzheimer’s disease and is metabolized via cytochrome P450 (CYP) 2D6 and CYP3A4/5. It...

Full description

Saved in:
Bibliographic Details
Main Authors: Yoshiyuki Kagawa, Yoshiaki Yamamoto, Ayami Ueno, Kengo Inomata, Mayu Tezuka, Takashi Osawa, Yasuharu Yazawa, Toshio Maeda, Tomokazu Obi
Format: article
Language:EN
Published: Karger Publishers 2021
Subjects:
Online Access:https://doaj.org/article/9092d961ecd94bbf8758a46b3d1fdcea
Tags: Add Tag
No Tags, Be the first to tag this record!